These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20804992)

  • 21. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery.
    Halkos ME; Cooper WA; Petersen R; Puskas JD; Lattouf OM; Craver JM; Guyton RA
    Ann Thorac Surg; 2006 Mar; 81(3):815-9. PubMed ID: 16488678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery.
    Chan V; Kulik A; Bourke ME; Ressler L; Mesana TG; Ruel M
    J Card Surg; 2007; 22(6):493-7. PubMed ID: 18039209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Best PJ; Steinhubl SR; Berger PB; Dasgupta A; Brennan DM; Szczech LA; Califf RM; Topol EJ;
    Am Heart J; 2008 Apr; 155(4):687-93. PubMed ID: 18371477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation.
    Hayashi F; Iijima R; Nakamura M; Sugi K
    J Cardiol; 2010 Jan; 55(1):34-40. PubMed ID: 20122546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-cardiac surgery in patients with coronary stents: the RECO study.
    Albaladejo P; Marret E; Samama CM; Collet JP; Abhay K; Loutrel O; Charbonneau H; Jaber S; Thoret S; Bosson JL; Piriou V
    Heart; 2011 Oct; 97(19):1566-72. PubMed ID: 21791513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does preoperative clopidogrel increase bleeding after coronary bypass surgery?
    Dasarathan C; Vaidyanathan K; Chandrasekaran D; Cherian KM
    Asian Cardiovasc Thorac Ann; 2011 Feb; 19(1):52-6. PubMed ID: 21357319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
    Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL;
    Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
    Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma sequestration: a good therapy to prevent the deleterious effect of clopidogrel when clopidogrel is used within one to four days of coronary bypass surgery.
    Schill DM
    Perfusion; 2010 Mar; 25(2):91-5. PubMed ID: 20427413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
    Finkel JB; Marhefka GD; Weitz HH
    Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy.
    Gansera B; Schmidtler F; Spiliopoulos K; Angelis I; Neumaier-Prauser P; Kemkes BM
    Thorac Cardiovasc Surg; 2003 Aug; 51(4):185-9. PubMed ID: 14502454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cessation of clopidogrel before major abdominal procedures.
    Chernoguz A; Telem DA; Chu E; Ozao-Choy J; Tammaro Y; Divino CM
    Arch Surg; 2011 Mar; 146(3):334-9. PubMed ID: 21422366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.